Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines

<p>Abstract</p> <p>Background</p> <p>The Hedgehog (HH) pathway promotes tumorigenesis in a diversity of cancers. Activation of the HH signaling pathway is caused by overexpression of HH ligands or mutations in the components of the HH/GLI1 cascade, which lead to increas...

Full description

Bibliographic Details
Main Authors: Kotani Hidehito, Kawagishi Aki, Mizuarai Shinji
Format: Article
Language:English
Published: BMC 2009-07-01
Series:Molecular Cancer
Online Access:http://www.molecular-cancer.com/content/8/1/44
_version_ 1818208089179947008
author Kotani Hidehito
Kawagishi Aki
Mizuarai Shinji
author_facet Kotani Hidehito
Kawagishi Aki
Mizuarai Shinji
author_sort Kotani Hidehito
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The Hedgehog (HH) pathway promotes tumorigenesis in a diversity of cancers. Activation of the HH signaling pathway is caused by overexpression of HH ligands or mutations in the components of the HH/GLI1 cascade, which lead to increased transactivation of GLI transcription factors. Although negative kinase regulators that antagonize the activity of GLI transcription factors have been reported, including GSK3β, PKA and CK1s, little is known regarding positive kinase regulators that are suitable for use on cancer therapeutic targets. The present study attempted to identify kinases whose silencing inhibits HH/GLI signalling in non-small cell lung cancer (NSCLC).</p> <p>Results</p> <p>To find positive kinase regulators in the HH pathway, kinome-wide siRNA screening was performed in a NSCLC cell line, A549, harboring the GLI regulatory reporter gene. This showed that p70S6K2-silencing remarkably reduced GLI reporter gene activity. The decrease in the activity of the HH pathway caused by p70S6K2-inhibition was accompanied by significant reduction in cell viability. We next investigated the mechanism for p70S6K2-mediated inhibition of GLI1 transcription by hypothesizing that GSK3β, a negative regulator of the HH pathway, is activated upon p70S6K2-silencing. We found that phosphorylated-GSK3β (Ser9) was reduced by p70S6K2-silencing, causing a decreased level of GLI1 protein. Finally, to further confirm the involvement of p70S6K2 in GLI1 signaling, down-regulation in GLI-mediated transcription by PI3KCA-inhibition was confirmed, establishing the pivotal role of the PI3K/p70S6K2 pathway in GLI1 cascade regulation.</p> <p>Conclusion</p> <p>We report herein that inhibition of p70S6K2, known as a downstream effector of the PI3K pathway, remarkably decreases GLI-mediated transactivation in NSCLC by reducing phosphorylated-GSK3β followed by GLI1 degradation. These results infer that p70S6K2 is a potential therapeutic target for NSCLC with hyperactivated HH/GLI pathway.</p>
first_indexed 2024-12-12T04:39:16Z
format Article
id doaj.art-0bfd2e4fa69b4861a0c8719c567b808b
institution Directory Open Access Journal
issn 1476-4598
language English
last_indexed 2024-12-12T04:39:16Z
publishDate 2009-07-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj.art-0bfd2e4fa69b4861a0c8719c567b808b2022-12-22T00:37:51ZengBMCMolecular Cancer1476-45982009-07-01814410.1186/1476-4598-8-44Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell linesKotani HidehitoKawagishi AkiMizuarai Shinji<p>Abstract</p> <p>Background</p> <p>The Hedgehog (HH) pathway promotes tumorigenesis in a diversity of cancers. Activation of the HH signaling pathway is caused by overexpression of HH ligands or mutations in the components of the HH/GLI1 cascade, which lead to increased transactivation of GLI transcription factors. Although negative kinase regulators that antagonize the activity of GLI transcription factors have been reported, including GSK3β, PKA and CK1s, little is known regarding positive kinase regulators that are suitable for use on cancer therapeutic targets. The present study attempted to identify kinases whose silencing inhibits HH/GLI signalling in non-small cell lung cancer (NSCLC).</p> <p>Results</p> <p>To find positive kinase regulators in the HH pathway, kinome-wide siRNA screening was performed in a NSCLC cell line, A549, harboring the GLI regulatory reporter gene. This showed that p70S6K2-silencing remarkably reduced GLI reporter gene activity. The decrease in the activity of the HH pathway caused by p70S6K2-inhibition was accompanied by significant reduction in cell viability. We next investigated the mechanism for p70S6K2-mediated inhibition of GLI1 transcription by hypothesizing that GSK3β, a negative regulator of the HH pathway, is activated upon p70S6K2-silencing. We found that phosphorylated-GSK3β (Ser9) was reduced by p70S6K2-silencing, causing a decreased level of GLI1 protein. Finally, to further confirm the involvement of p70S6K2 in GLI1 signaling, down-regulation in GLI-mediated transcription by PI3KCA-inhibition was confirmed, establishing the pivotal role of the PI3K/p70S6K2 pathway in GLI1 cascade regulation.</p> <p>Conclusion</p> <p>We report herein that inhibition of p70S6K2, known as a downstream effector of the PI3K pathway, remarkably decreases GLI-mediated transactivation in NSCLC by reducing phosphorylated-GSK3β followed by GLI1 degradation. These results infer that p70S6K2 is a potential therapeutic target for NSCLC with hyperactivated HH/GLI pathway.</p>http://www.molecular-cancer.com/content/8/1/44
spellingShingle Kotani Hidehito
Kawagishi Aki
Mizuarai Shinji
Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines
Molecular Cancer
title Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines
title_full Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines
title_fullStr Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines
title_full_unstemmed Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines
title_short Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines
title_sort inhibition of p70s6k2 down regulates hedgehog gli pathway in non small cell lung cancer cell lines
url http://www.molecular-cancer.com/content/8/1/44
work_keys_str_mv AT kotanihidehito inhibitionofp70s6k2downregulateshedgehogglipathwayinnonsmallcelllungcancercelllines
AT kawagishiaki inhibitionofp70s6k2downregulateshedgehogglipathwayinnonsmallcelllungcancercelllines
AT mizuaraishinji inhibitionofp70s6k2downregulateshedgehogglipathwayinnonsmallcelllungcancercelllines